Explore 3Q25 market rallies driven by strong US earnings, AI, and Fed rate cuts. Understand inflation, labor, and the outlook ...
Zelenectide pevedotin (BT8009) demonstrated a well-tolerated safety profile and promising antitumor activity in patients with ...
The investigational combination of bezuclastinib (CGT9486) and sunitinib (Sutent) yielded clinically meaningful benefits with favorable tolerability in patients with gastrointestinal stromal tumors ...
Record silver production of 1.35 million ("M") ounces ("oz") up 278% vs. the prior year driven by the new Zgounder plant; and up 29% increase quarter-over-quarter (“QoQ”), driven by record throughput ...
Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) today reported results for the three and nine months ended September 30, 2025. Third Quarter ...
Elementary teachers can help students feel confident tackling big goals by encouraging them to focus on getting a little bit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback